Children's Viewing Behavior

April 29, 2026 updated by: SightGlass Vision, Inc.

Children's Viewing Behavior in Myopia Control Spectacles

The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Indiana
      • Bloomington, Indiana, United States, 47405
        • Recruiting
        • Indiana University
        • Contact:
          • Pete S Kollbaum, OD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

A person is eligible for inclusion in the study if he/she:

  • Is 7-14 years of age, inclusive
  • Requires spherical spectacle lenses within the power range available for the study lenses
  • Parent/guardian has read and understood the informed consent form, and the child has provided age-appropriate assent
  • Is willing and able to follow instructions and maintain the appointment schedule
  • Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best corrected
  • Has had a self-reported oculo-visual examination in the last two years
  • Spectacle cylinder of ≤ -0.75DC in both eyes

Exclusion Criteria:

A person will be excluded from the study if he/she:

  • Is unable to complete the necessary study activities
  • Has any systemic disease affecting ocular health
  • Is using any systemic or topical medications (including pharmaceutical myopia control therapy) that will affect ocular health
  • Is aphakic

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SightGlass Vision Test Arm 1
Single vision, impact-resistant spectacle lenses
Use of lenses may reduce the rate of progression of juvenile myopia
Experimental: SightGlass Vision Test Arm 2
Single vision, impact-resistant spectacle lenses
Use of lenses may reduce the rate of progression of juvenile myopia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Activity dependent, gaze location in myopia control spectacles
Time Frame: 2 months
2 months
Subjective/objective quantification of activity via survey or observation
Time Frame: 2 months
2 months
Pupil size
Time Frame: 2 months
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 22, 2025

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

November 12, 2025

First Submitted That Met QC Criteria

November 12, 2025

First Posted (Actual)

November 17, 2025

Study Record Updates

Last Update Posted (Actual)

April 30, 2026

Last Update Submitted That Met QC Criteria

April 29, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CPRO-2507-002

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia

Clinical Trials on Novel spectacle lens design

Subscribe